China Life Insurance Suspected the Ma Yun System

It is reported that China Life alone submitted a privatization offer to the board of directors of Aikang Guobin, forming a situation in which the Yunfeng Fund was bidding. The news has not yet been confirmed by Ikang Guobin and China Life.

China Life Insurance wants to stir up the Ma Yun system to take over the dream? Doubt and Yunfeng bid for Ikang Guobin

On June 6, 2016, the Yunfeng Fund of Ma Yun Department issued a privatization offer to Aikang Guobin. On June 7, Zhang Kangang, CEO of Aikang Guobin, led the consortium to withdraw the offer to the board of directors. On June 8, Zhang Ligang issued an internal letter. Supporting the “acquisitive and friendly investor’s acquisition of Aikang”, the same day, the US Health Leading Group announced the withdrawal of the privatization of the Ikang Guobin offer: this series of changes made the market expect the privatization of Ikang Guobin to settle down, the funds The powerful Yunfeng Fund became the sole buyer consortium.

However, after a week, the incident was suspected of wavering again. It was reported that China Life, which had been a member of the consortium led by Zhang Ligang, had submitted a separate privatization plan to the board of directors of the Ikang Guobin. The offer was slightly higher than the American Depositary Shares per share. The US dollar formed a bidding situation with the Yunfeng Fund.

The news has not yet been publicly confirmed by Ikang Guobin and China Life.

China Life Insurance is a member of the Zhang Ligang consortium. At the beginning of 2016, in the context of Zhang Ligang’s management of Aikang Guobin’s management blocking the competition of competitors’ beautiful health (hereinafter referred to as “Year of Health”), he joined the Zhang Ligang consortium with Alibaba. .

For Zhang Ligang’s open letter suggesting support for Yunfeng Fund, and China Life’s decision to bid, the aforementioned report stated that Zhang Ligang announced on June 7 that his lead consortium had withdrawn the privatization offer and that it was not known as one of the members of the consortium’s China Life. The person was very dissatisfied with this, so he submitted a separate bid offer to the board of directors of Ikang Guobin.

If China Life’s bidding is true, it means that the privatization of Ikang Guobin is once again caught in the bidding situation of the two parties, but this time the bidding is between China Life and Yunfeng Fund, and the last time in the case of Zhang Ligang’s representative Between management and the health of the United States.

At the end of August 2015, the Chinese company Aikang Guobin announced that it had received the privatization offer from the CEO Zhang Ligang, and embarked on the road of delisting. Three months later, Ikang Guobin’s domestic competitor’s health in the United States suddenly appeared. Make an offer to compete for the right to privatize the Aikang Guobin.

Mei Nian Health said that it wants to acquire Aikang Guobin to promote the integration of its private medical examination industry and raise industry standards. At that time, the company was carrying out the acquisition of another giant Ci Ming medical examination in the private medical examination industry, and the backdoor A-share Jiangsu Sanyou For the listing work, if the Aikang Guobin is included in the listing, the three giants in the domestic private medical examination industry will realize the merger and listing of A shares.

Automatic Nucleic Acid Extractor

Nucleic acid extraction instrument is an instrument that automatically completes the nucleic acid extraction of samples by applying the supporting nucleic acid extraction reagents. Widely used in disease control centers, clinical disease diagnosis, blood transfusion safety, forensic identification, environmental microbial testing, food safety testing, animal husbandry and molecular biology research and other fields.
Using magnetic beads as the carrier, using the principle that magnetic beads adsorb nucleic acid under high salt and low pH value, and separate from nucleic acid under low salt and high pH value, and then move the magnetic beads or transfer the liquid to realize the entire extraction and purification process of nucleic acid. Due to the uniqueness of its principle, it can be designed into a variety of throughputs, which can be extracted from a single tube or 8-96 samples, and its operation is simple and fast. It only takes 30-45 minutes to extract 96 samples, which greatly improves the The experimental efficiency is low and the cost is low, so it can be used in different laboratories, and it is the mainstream instrument on the market.

Features of Magnetic Bead Nucleic Acid Extractor
1. Enables automated, high-throughput operations.
2. Simple and fast operation.
3. Safety and environmental protection.
4. High purity and high yield.
5. No pollution and stable results.
6. Low cost and easy to be widely used.
7. Different types of samples can be processed simultaneously.

Nucleic Acid Extraction System,Automatic Nucleic Acid Extractor,Nucleic Acid Extraction Machine,Nucleic Acid Extraction Instrument

Jilin Sinoscience Technology Co. LTD , https://www.jlgkscience.com